ECIO 2022 will be held in Vienna, Austria, from 24-27 April 2022
The ECIO 2022 program covers everything there is to know about intervention oncology, ranging from established therapies to new applications, the most recent in research and the latest tools and materials.
ECIO is the world’s most comprehensive platform for the fourth pillar of cancer care education and knowledge exchange, welcoming over 1,450 international delegates throughout Europe.
Prof. Thierry de Baere from Gustave Roussy Cancer Center and Prof. Boris Guiu from Montpellier University Hospital authored a poster presenting the results of the pilot study conducted with Epione®. This study concludes that percutaneous ablation of primary and secondary malignant liver tumors using the Epione® robotic device is feasible and safe.
- P-28 “Evaluation of a new CT-guided robotic system for thermal ablation of liver tumors: a prospective pilot study.”
Epione® is a unique robotic-assisted technology that enables physicians to Plan, Target, Deliver and Confirm tumor ablation.
Meet us there to have an opportunity to speak with the Quantum Surgical team and to learn about Epione®.
We look forward to seeing you at the event.
- 24-27 April 2022